what is glp-1 microdose Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide People Are Microdosing Weight-Loss Drugs

Results Out of a total of 1436 identified unique records ( Figure 1 ), we excluded 1372 records for not meeting the inclusion criteria based on title or abstract or upon further evaluation of the full text

The SURMOUNT-1 trial demonstrated a 15 mg dosage of tirzepatide in non-diabetic obese subjects leads to 20.9% weight loss at week 72 with sustained weight loss during a 3-year extension period [134,137]

Fresh fruits, vegetables, salads, and lean proteins provide more nutrients and are more satisfying than a shake, bar, or processed snack

If youve recently been on semaglutide or tirzepatide elsewhere, note your previous dose on your intake form and your provider will align with where you left off